Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
25 Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring
Compose a Response to This Article
Other responses
No responses have been published for this article.
